Vanguard Group’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q4 | – | Sell |
-8,240,391
| Closed | -$28M | – | 4179 |
|
2018
Q3 | $28M | Buy |
8,240,391
+194,437
| +2% | +$661K | ﹤0.01% | 2421 |
|
2018
Q2 | $30.3M | Buy |
8,045,954
+278,315
| +4% | +$1.05M | ﹤0.01% | 2377 |
|
2018
Q1 | $31.8M | Sell |
7,767,639
-126,220
| -2% | -$516K | ﹤0.01% | 2311 |
|
2017
Q4 | $36.7M | Buy |
7,893,859
+328,889
| +4% | +$1.53M | ﹤0.01% | 2224 |
|
2017
Q3 | $53.7M | Buy |
7,564,970
+366,701
| +5% | +$2.6M | ﹤0.01% | 2009 |
|
2017
Q2 | $52M | Buy |
7,198,269
+349,521
| +5% | +$2.53M | ﹤0.01% | 1998 |
|
2017
Q1 | $42.2M | Buy |
6,848,748
+302,986
| +5% | +$1.87M | ﹤0.01% | 2090 |
|
2016
Q4 | $38.4M | Buy |
6,545,762
+146,770
| +2% | +$860K | ﹤0.01% | 2104 |
|
2016
Q3 | $34M | Buy |
6,398,992
+197,290
| +3% | +$1.05M | ﹤0.01% | 2113 |
|
2016
Q2 | $41.1M | Sell |
6,201,702
-125
| -0% | -$827 | ﹤0.01% | 1991 |
|
2016
Q1 | $29M | Buy |
6,201,827
+199,730
| +3% | +$933K | ﹤0.01% | 2125 |
|
2015
Q4 | $30.3M | Sell |
6,002,097
-1,112,591
| -16% | -$5.62M | ﹤0.01% | 2124 |
|
2015
Q3 | $25M | Buy |
7,114,688
+245,837
| +4% | +$865K | ﹤0.01% | 2187 |
|
2015
Q2 | $68.6M | Buy |
6,868,851
+336,631
| +5% | +$3.36M | ﹤0.01% | 1765 |
|
2015
Q1 | $83.2M | Buy |
6,532,220
+841,982
| +15% | +$10.7M | 0.01% | 1625 |
|
2014
Q4 | $80.5M | Buy |
5,690,238
+99,499
| +2% | +$1.41M | 0.01% | 1559 |
|
2014
Q3 | $76.9M | Buy |
5,590,739
+1,430,465
| +34% | +$19.7M | 0.01% | 1542 |
|
2014
Q2 | $64M | Buy |
4,160,274
+40,094
| +1% | +$617K | 0.01% | 1707 |
|
2014
Q1 | $70.2M | Buy |
4,120,180
+1,658,084
| +67% | +$28.3M | 0.01% | 1598 |
|
2013
Q4 | $31.9M | Buy |
2,462,096
+167,368
| +7% | +$2.17M | ﹤0.01% | 1993 |
|
2013
Q3 | $23.2M | Buy |
2,294,728
+32,955
| +1% | +$333K | ﹤0.01% | 2060 |
|
2013
Q2 | $16.9M | Buy |
+2,261,773
| New | +$16.9M | ﹤0.01% | 2126 |
|